Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group
Gabriele Antonarelli, Chiara Corti, Paolo Andrea Zucali, Matteo Perrino, Sara Manglaviti, Giuseppe Lo Russo, Gianluca Maria Varano, Piermario Salvini, Giuseppe Curigliano, Chiara Catania, Fabio Conforti, Tommaso De Pas
Topics & Concepts
Thymic carcinomaSunitinibMedicineThymomaInternal medicineRefractory (planetary science)Adverse effectDosingToxicityGastroenterologyOncologyChemotherapyResponse Evaluation Criteria in Solid TumorsSurgeryUrologyCancerPhases of clinical researchPhysicsAstrobiologyMyasthenia Gravis and ThymomaSoft tissue tumors and treatmentVascular Malformations and Hemangiomas